Resultados de la búsqueda 211-220 of 10360 for immunosuppressant drugs

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Testing The Addition Of A New Drug ... Onvansertib is a drug that binds to and inhibits ... immunosuppressants. Exploratory Goals. To evaluate ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    [1, 2] The solid tumor stroma acts as an immunosuppressive cloud that ... Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Testing The Addition Of A New Drug ... Onvansertib is a drug that binds to and inhibits ... immunosuppressants. Exploratory Goals. To evaluate ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Testing The Addition Of A New Drug ... Onvansertib is a drug that binds to and inhibits ... immunosuppressants. Exploratory Goals. To evaluate ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  9. Trasplante de páncreas - Médicos y departamentos - Mayo Clinic

    Therapeutic drug monitoring of immunosuppressive drugs: A field constantly in motion. Therapeutic Drug Monitoring. 2025; doi:10.1097/FTD.0000000000001286 ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...